TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
160 hedge funds and large institutions have $425M invested in Tvardi Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+15
Holders Change %
+10.34%
% of All Funds
3.24%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
32
Increased
32
Reduced
48
Closed
17
Calls
$6.17M
Puts
$3.94M
Net Calls
+$2.22M
Net Calls Change
-$1.33M
Top Buyers
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.26M |
| 2 |
Goldman Sachs
New York
|
+$3.72M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$3.35M |
| 4 |
First Manhattan
New York
|
+$2.72M |
| 5 |
Renaissance Technologies
New York
|
+$2.67M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.59M |
| 2 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$3.24M |
| 3 |
D.E. Shaw & Co
New York
|
-$2.45M |
| 4 |
C
Chescapmanager
Baltimore,
Maryland
|
-$2.16M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$2.03M |
